The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...

Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

Straight from the trenches of caring for their own babies and toddlers through cold and flu season, six pediatricians share ...

To reduce the odds of catching the flu and colds, experts say consider tried-and-true prevention methods like hand washing and mask wearing.

The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...

China has reported two more H9N2 avian flu infections in humans, both of them patients from Hunan province in the southern ...

This is the year to be optimistic about Alzheimer’s disease says one of Australia’s leading dementia researchers.